The Sarah Cannon Research Institute

Chattanooga, Tennessee 37404

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Breast Cancer Clinical Trial
DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]
Status: Enrolling, Phase III
Updated: 12/31/1969
The Sarah Cannon Research Institute
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
The Sarah Cannon Research Institute
mi
from
Chattanooga, TN
Click here to add this to my saved trials